SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001294002-06-000018
Filing Date
2006-06-15
Accepted
2006-06-15 18:32:23
Documents
1
Period of Report
2006-06-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 2853
  Complete submission text file 0001294002-06-000018.txt   4630
Mailing Address 5931 DARWIN COURT CARLSBAD CA 92008
Business Address 5931 DARWIN COURT CARLSBAD CA 92008 7604317080
IMMUNE RESPONSE CORP (Issuer) CIK: 0000817785 (see all company filings)

IRS No.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 535 MADISON AVENUE NEW YORK NY 10022
Business Address 212 418-8566
Hochman David P (Reporting) CIK: 0001292834 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-18006 | Film No.: 06908324